Search research articles
Contact Us
Filters
Showing results (331-340 of 413) with videos related to
Page
of 42
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems
Jae H Hong, Cornelius J Clancy, Shaoji Cheng, et al.
Transplantation
|
August 2, 2016
Surgical Site Infections After Liver Transplantation: Emergence of Multidrug-Resistant Bacteria and Implications for Prophylaxis and Treatment Strategies
J Alexander Viehman, Cornelius J Clancy, Lloyd Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2021
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients
M Hong Nguyen, Ryan K Shields, Liang Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 15, 2016
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K Shields, Brian A Potoski, Ghady Haidar, et al.
Antimicrobial Agents and Chemotherapy
|
September 19, 2019
Pharmacokinetics and Dialytic Clearance of Isavuconazole During In Vitro and In Vivo Continuous Renal Replacement Therapy
M Biagi, D Butler, X Tan, et al.
Antimicrobial Agents and Chemotherapy
|
December 24, 2014
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia
Ryan K Shields, M Hong Nguyen, Brian A Potoski, et al.
Journal of Neurotrauma
|
December 23, 2020
Meeting Proceedings for SCI 2020: Launching a Decade of Disruption in Spinal Cord Injury Research
Leslie R Morse, Edelle C Field-Fote, Jose Contreras-Vidal, et al.
Physical Therapy
|
December 21, 2010
The revised research agenda for physical therapy
Marc S Goldstein, David A Scalzitti, Rebecca L Craik, et al.
The Journal of Antimicrobial Chemotherapy
|
August 21, 2016
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study
Kady Phe, Ryan K Shields, Frank P Tverdek, et al.
Antimicrobial Agents and Chemotherapy
|
March 16, 2016
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
Deanna J Buehrle, Ryan K Shields, Liang Chen, et al.
Page
of 42
Search research articles
Search
Showing results (331-340 of 413) with videos related to
Sort By:
Page
of 42
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems
Jae H Hong, Cornelius J Clancy, Shaoji Cheng, et al.
Transplantation
|
August 2, 2016
Surgical Site Infections After Liver Transplantation: Emergence of Multidrug-Resistant Bacteria and Implications for Prophylaxis and Treatment Strategies
J Alexander Viehman, Cornelius J Clancy, Lloyd Clarke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2021
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients
M Hong Nguyen, Ryan K Shields, Liang Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 15, 2016
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K Shields, Brian A Potoski, Ghady Haidar, et al.
Antimicrobial Agents and Chemotherapy
|
September 19, 2019
Pharmacokinetics and Dialytic Clearance of Isavuconazole During In Vitro and In Vivo Continuous Renal Replacement Therapy
M Biagi, D Butler, X Tan, et al.
Antimicrobial Agents and Chemotherapy
|
December 24, 2014
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia
Ryan K Shields, M Hong Nguyen, Brian A Potoski, et al.
Journal of Neurotrauma
|
December 23, 2020
Meeting Proceedings for SCI 2020: Launching a Decade of Disruption in Spinal Cord Injury Research
Leslie R Morse, Edelle C Field-Fote, Jose Contreras-Vidal, et al.
Physical Therapy
|
December 21, 2010
The revised research agenda for physical therapy
Marc S Goldstein, David A Scalzitti, Rebecca L Craik, et al.
The Journal of Antimicrobial Chemotherapy
|
August 21, 2016
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study
Kady Phe, Ryan K Shields, Frank P Tverdek, et al.
Antimicrobial Agents and Chemotherapy
|
March 16, 2016
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
Deanna J Buehrle, Ryan K Shields, Liang Chen, et al.
Page
of 42